Laidlaw Wealth Management’s abrdn Healthcare Investors HQH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-63,331
Closed -$1.62M 402
2021
Q3
$1.62M Sell
63,331
-7,385
-10% -$194K 0.42% 74
2021
Q2
$1.82M Sell
70,716
-5,084
-7% -$125K 0.47% 57
2021
Q1
$1.85M Buy
75,800
+140
+0.2% +$3.41K 0.63% 44
2020
Q4
$1.8M Buy
75,660
+4,103
+6% +$89.1K 0.38% 70
2020
Q3
$1.48M Sell
71,557
-3,642
-5% -$77K 0.66% 48
2020
Q2
$1.6M Buy
75,199
+42,148
+128% +$859K 0.84% 35
2020
Q1
$589K Buy
33,051
+17,123
+108% +$338K 0.39% 76
2019
Q4
$333K Buy
+15,928
New +$315K 0.21% 119

Other funds holding HQH

Laidlaw Wealth Management's HQH Position: Q4 2021 in Review

Laidlaw Wealth Management sold out of abrdn Healthcare Investors (HQH) in Q4 2021, closing a stake of 63,331 shares — an estimated $1.62M sold.

Laidlaw Wealth Management first reported a position in HQH in Q4 2019 and held it in 8 quarters. The position peaked at $1.85M in Q1 2021. 105 funds tracked by Wall St. Rank hold HQH as of Q4 2021.

  • Laidlaw Wealth Management reported no remaining abrdn Healthcare Investors position as of Q4 2021 after selling out during the quarter.
  • Laidlaw Wealth Management sold 63,331 abrdn Healthcare Investors shares in Q4 2021, an estimated $1.62M.
  • Laidlaw Wealth Management first reported a position in abrdn Healthcare Investors in Q4 2019 and held it in 8 quarters.
  • Laidlaw Wealth Management's abrdn Healthcare Investors position peaked at $1.85M in Q1 2021.
  • 105 funds tracked by Wall St. Rank held abrdn Healthcare Investors as of Q4 2021.

Based on Laidlaw Wealth Management's 13F filing for Q4 2021, filed 14 Feb 2022.